Literature DB >> 20609818

Exchange transfusion before cardiopulmonary bypass in sickle cell disease.

Karl A Bocchieri1, S Jacob Scheinerman, L Michael Graver.   

Abstract

Cardiac operations in patients with sickle cell disease present the surgical team with many challenges. We describe a method of complete intraoperative exchange transfusion in the operating room that reduces the hemoglobin S (Hb S) level to less than 5%, without preoperative exchange transfusions. Plasma and platelet fractions separated intraoperatively from the patient's native red cell mass were used, in addition to hemoconcentration while on cardiopulmonary bypass, to effectively reduce the red cell and clotting factor transfusion requirements after the procedure. The technique is useful in reducing transfusion requirements, avoiding cardiovascular stress associated with exchange transfusion before the operation, and can be used in urgent situations. Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609818     DOI: 10.1016/j.athoracsur.2009.08.037

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Sickle Cell Hemoglobin C Disease Patient Undergoing Coronary Artery Bypass Grafting with Complete Exchange Blood Transfusion during Cardiopulmonary Bypass.

Authors:  Francesca Mullins; Shawn Ott; Nakia Mister; Jeffrey Travis
Journal:  J Extra Corpor Technol       Date:  2018-06

2.  Perioperative considerations in a sickle cell patient undergoing cardiopulmonary bypass.

Authors:  Monish S Raut; Jasbir Singh Khanuja; Sushant Srivastava
Journal:  Indian J Anaesth       Date:  2014-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.